Measuring Mortality Reductions in Cancer Screening Trials

Author： Hanley James A.  

Publisher： Oxford University Press

ISSN： 0193-936X

Source： Epidemiologic Reviews, Vol.33, Iss.1, 2011-05, pp. : 36-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Cancer in the Canadian Breast Screening Trials

By  

THE BREAST JOURNAL, Vol. 21, Iss. 4, 2015-07 ,pp. : 457-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

The colorectal cancer mortality‐to‐incidence ratio as an indicator of global cancer screening and care

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1563-1569

John Wiley & Sons Inc

Access to resources Recommend Favorite

Understanding Immigrant Chinese Americans’ Participation in Cancer Screening and Clinical Trials

By Lin Jennifer   Finlay Alyssa   Tu Angela   Gany Francesca  

Journal of Community Health, Vol. 30, Iss. 6, 2005-12 ,pp. : 451-466

Springer Publishing Company

Access to resources Recommend Favorite

Update on Screening in Prostate Cancer Based on Recent Clinical Trials

By  

Reviews on Recent Clinical Trials, Vol. 6, Iss. 1, 2011-01 ,pp. : 7-15

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1713-1724

John Wiley & Sons Inc

Access to resources Recommend Favorite